跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fentare - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Fentare
Approved
STANDARD
Fentare
Yichang Humanwell Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c6cb8a812aeb53a5
Company
Yichang Humanwell Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
c6cb8a812aeb53a5
Drug Approval Philippines Name
Fentare
Product Name
Fentare
Registration Number
DRP-15137
Brand Name
Fentare
Generic Name
Remifentanil (as hydrochloride)
Dosage Form
Lyophilized Powder for Injection (I.V.)
Dosage Strength
2mg
Manufacturer
Yichang Humanwell Pharmaceutical Co., Ltd.
Importer
Philcare Pharma, Inc.
Distributor
Philcare Pharma, Inc.
Company Detail Path
/organization/yichang-humanwell-pharmaceutical-co-ltd
Issuance Date
10 May 2024
Expiry Date
10 May 2029
Pharmacologic Category
Opioid Anesthetic
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c6cb8a812aeb53a5
Type
Standard
Back to Philippines FDA Approvals